Home / Market News / $SOLV

$SOLV news and market catalysts

The 24 most recent market catalysts affecting $SOLV, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.

24 catalysts 6 high impact 20 bullish 2 bearish Healthcare
Nov 18, 2026 Corporate Catalyst Bullish Impact 85
Solventum Completes Major ERP Cutover and Raises Profit Guidance
Solventum announced the successful completion of its largest ERP cutover, a critical step in its separation from 3M, which significantly de-risks its operations and is expected to …
Nov 18, 2026 Corporate Catalyst Bullish Impact 65
UBS Upgrades SOLV Energy to Buy
Investment bank UBS upgraded SOLV Energy's stock rating from Neutral to Buy and established a price target of $37. This upgrade follows the company's third-quarter 2026 earnings re…
Nov 16, 2026 Corporate Catalyst Bullish Impact 65
SOLV Energy Highlights Growing Customer Demand for Full-Lifecycle Infrastructure Partnerships at RE+ 2026
SOLV Energy, a private company, announced a significant $9.2 billion project backlog as of Q3 2026, indicating strong demand for its full-lifecycle renewable energy infrastructure …
Nov 13, 2026 Corporate Catalyst Bearish Impact 60
SOLV Energy Price Target Cut by Evercore ISI Group
Evercore ISI Group has lowered its price target for SOLV Energy from $51.00 to $43.00, reflecting a re-evaluation of the company's equity. This action by a major investment bank is…
Nov 12, 2026 Corporate Catalyst Bullish Impact 75
SOLV Energy Reports Third Quarter 2026 Financial Results and Raises 2026 Outlook
SOLV Energy reported its Q3 2026 financial results, highlighting an increase in quarterly revenue. Crucially, the company also revised its full fiscal year 2026 revenue outlook upw…
Nov 9, 2026 Corporate Catalyst Bullish Impact 65
3M Amends Raw-Material Supply Agreement with Solventum
Solventum Corporation has amended its raw-material supply agreement with 3M, its former parent company. This amendment is significant because it establishes set purchase volumes, w…
Nov 6, 2026 Corporate Catalyst Bullish Impact 55
Berenberg Upgrades Solvay to Hold
Berenberg, a financial services firm, upgraded Solvay SA's stock rating to 'Hold' and affirmed its price target. This action follows Solvay's third-quarter 2026 earnings call, indi…
Nov 6, 2026 Corporate Catalyst Neutral Impact 65
Wells Fargo and Piper Sandler Adjust Price Targets on Solventum
This 8-K filing discloses that two prominent financial institutions, Wells Fargo and Piper Sandler, have raised their price targets for Solventum Corporation. These adjustments occ…
Nov 5, 2026 Corporate Catalyst Bullish Impact 92
Solventum Reports Third Quarter 2026 Financial Results
Solventum Corporation announced robust third-quarter 2026 financial results, surpassing FactSet consensus estimates for both revenue ($1.95 billion vs. $1.93 billion) and adjusted …
Nov 2, 2026 Corporate Catalyst Bullish Impact 75
SOLV Energy Expands High-Voltage Infrastructure Capabilities with Acquisition of ASB Energy Services
SOLV Energy, Inc. announced the acquisition of ASB Energy Services on November 2, 2026. This strategic move is designed to expand SOLV Energy's high-voltage infrastructure capabili…
Oct 19, 2026 Corporate Catalyst Bullish Impact 65
Solventum Receives FDA Clearance For Combined Use Of Restrata Synthetic Electrospun Fiber Matrix, Solventum V.A.C. Therapy
Solventum (SOLV) announced that the FDA has granted 510(k) clearance for the combined use of its Restrata Synthetic Electrospun Fiber Matrix and Solventum V.A.C. Therapy. This regu…
Aug 13, 2026 Corporate Catalyst Bullish Impact 85
SOLV Energy shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY26 sales guidance above analyst estimates.
This headline is a significant corporate catalyst for SOLV Energy, directly impacting its stock price positively due to better-than-expected financial results and an optimistic fut…
Aug 6, 2026 Corporate Catalyst Bullish Impact 55
UBS Maintains Buy on Solventum, Raises Price Target to $101
UBS analyst Kevin Caliendo maintained a 'Buy' rating on Solventum (SOLV) and raised the price target from $95 to $101. This action signals a positive outlook from a prominent finan…
Aug 6, 2026 Corporate Catalyst Bearish Impact 75
Solventum shares are trading lower after the company reported Q2 financial results. The stock initially rallied yesterday after the market closed, but it has since reversed.
This headline highlights a direct corporate catalyst: a company's earnings report. The initial rally followed by a reversal suggests that while headline numbers might have been ini…
Aug 6, 2026 Corporate Catalyst Bullish Impact 55
Piper Sandler Maintains Overweight on Solventum, Raises Price Target to $105
Piper Sandler analyst Jason Bednar has maintained an 'Overweight' rating on Solventum (SOLV) and raised the price target from $92 to $105. This action signals increased confidence …
Aug 6, 2026 Corporate Catalyst Bullish Impact 55
Wedbush Maintains Outperform on Solventum, Raises Price Target to $101
Wedbush analyst Michael Piccolo has maintained an 'Outperform' rating on Solventum (SOLV) and raised the price target from $94 to $101. This action signals increased confidence in …
Aug 6, 2026 Market Technicals Bullish Impact 55
Keybanc Maintains Overweight on Solventum, Raises Price Target to $102
Keybanc analyst Brett Fishbin has updated their coverage on Solventum, raising the price target from $93 to $102 while maintaining an Overweight rating. This action indicates a str…
Aug 6, 2026 Corporate Catalyst Bullish Impact 55
Stifel Maintains Buy on Solventum, Raises Price Target to $100
Stifel analyst Rick Wise maintained a 'Buy' rating on Solventum and raised the price target from $90 to $100. This analyst action signals continued confidence in the company's pros…
Aug 6, 2026 Corporate Catalyst Bullish Impact 55
BTIG Maintains Buy on Solventum, Raises Price Target to $95
BTIG analyst Ryan Zimmerman maintained a 'Buy' rating on Solventum and raised the price target from $91 to $95. This action signals continued analyst confidence in SOLV's prospects…
Aug 5, 2026 Corporate Catalyst Neutral Impact 75
SolventumĀ Plans To Separate Its Health Information Systems Operations As Part Of Its Portfolio Optimization Strategy
Solventum is pursuing a separation of its Health Information Systems business as part of an ongoing portfolio optimization strategy. This move is significant because it indicates a…
Aug 5, 2026 Corporate Catalyst Bullish Impact 85
Solventum shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY26 adjusted EPS guidance above estimates.
This headline is a significant corporate catalyst for Solventum, as better-than-expected earnings and raised guidance directly impact investor perception and valuation. The positiv…
Aug 5, 2026 Corporate Catalyst Bullish Impact 92
Solventum Q2 Adj. EPS $2.55 Beats $1.91 Estimate, Sales $2.209B Beat $2.156B Estimate
Solventum (SOLV) announced Q2 adjusted EPS of $2.55, significantly surpassing the $1.91 analyst consensus, and sales of $2.209 billion, also beating the $2.156 billion estimate. Th…
Aug 5, 2026 Corporate Catalyst Bullish Impact 85
Solventum Raises FY2026 Adj EPS Guidance from $6.60 to $7.10-$7.20 vs $6.55 Est
Solventum (SOLV) has announced a substantial increase in its adjusted EPS guidance for fiscal year 2026, moving from $6.60 to a range of $7.10-$7.20. This new guidance is notably h…
Jul 28, 2026 Corporate Catalyst Bullish Impact 65
UBS Upgrades Solventum to Buy, Announces $95 Price Target
UBS analyst Kevin Caliendo upgraded Solventum (SOLV) from Neutral to Buy, accompanied by a new $95 price target. This upgrade indicates a more optimistic outlook from a prominent f…
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.